2024 annual financial data
Inovio Pharmaceuticals 2024 Financial results
Direct answer
Revenue was 217,756 USD.
Operating income was -112,398,922 USD and net income was -107,254,126 USD.
Operating cash flow was -104,076,553 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 217,756 USD
- Operating income
- -112,398,922 USD
- Net income
- -107,254,126 USD
- Operating cash flow
- -104,076,553 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Inovio Pharmaceuticals financial years